Patients should contact their healthcare provider if headaches are severe, persistent, or progressively worsening despite conservative management measures
Its key advantage is high specificity for GH release without triggering ACTH or cortisol elevation, making it one of the safer GH secretagogues with minimal off-target hormonal effects [1] [3]
Reliance on monitoring, or retrospective justifications, reflects a fundamental control gap, if not ensured by design
Lipotropic compounds are well-tolerated at therapeutic doses
An emerging strategy to mitigate barriers related to NuSH therapy is microdosing, an off- label technique where lower or fractional doses are used to improve access, affordability, and/ or tolerability Microdosing GLP- 1RA and GIP/GLP- 1RA has been advertised by direct- to- consumer telehealth companies and on social media platforms and implemented in clinical practice without peer- reviewed, evidence- based guidance